Evidence map›Paper›PMID 36626499›Full record

ArticleMedicine2022

Whipple's disease review, prevalence, mortality, and characteristics in the United States: A cross-sectional national inpatient study.

Akram I Ahmad, Colin Wikholm, Ioannis Pothoulakis, Claire Caplan, Arielle Lee, Faith Buchanan, Won Kyoo Cho

Open access · goldAbstract read
In one paragraph

Article in Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  2. Article
  3. Whipple disease presenting with severe weight loss, seronegative inflammatory arthritis, and culture-negative endocarditis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  4. Review
  5. PulmonaryRespirology case reports · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Whipple's disease in southern New Brunswick, Canada: A case series.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2025
    Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Akram I AhmadDepartment of Internal Medicine, MedStar Washington Hospital Center Rather than Georgetown, Washington, D.C., USA.ORCID 0000-0001-5168-8050
Colin WikholmGeorgetown University School of Medicine, Washington, D.C., USA.
Ioannis PothoulakisDepartment of Internal Medicine, MedStar Washington Hospital Center Rather than Georgetown, Washington, D.C., USA.
Claire CaplanGeorgetown University School of Medicine, Washington, D.C., USA.
Arielle LeeGeorgetown University School of Medicine, Washington, D.C., USA.
Faith BuchananDepartment of Internal Medicine, MedStar Washington Hospital Center Rather than Georgetown, Washington, D.C., USA.
Won Kyoo ChoDepartment of Internal Medicine, MedStar Washington Hospital Center Rather than Georgetown, Washington, D.C., USA.
MedStar Washington Hospital Center · USGeorgetown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whipple's disease is a rare multiorgan systemic disease caused by Tropheryma whipplei infection that may present with a wide range of signs and symptoms. This study aim to comprehensively review and determine the inpatient prevalence, mortality, risk factors, and reasons for hospitalization of patients with Whipple's disease. ICD-10 codes were used to identify admissions with Whipple's disease during the years 2016 to 2018. Characteristics of admissions with and without Whipple's disease were compared. The most common reasons for hospitalization were identified in admissions with Whipple's disease. The prevalence of Whipple's disease was 4.6 per 1 million hospitalizations during the study period. Whipple's disease admissions were significantly older than other hospitalizations, with a mean age of 60.2 ± 1.6 years compared to 50.0 ± 0.1. Males were more likely to have Whipple's disease and represented approximately two-thirds of hospitalizations. A disproportionate number of admissions occurred in the Midwest. Patients with Whipple's disease were most commonly admitted for gastrointestinal disease, followed by systemic infection, cardiovascular/circulatory disease, musculoskeletal disease, respiratory disease, and neurological disease. High mortality was seen in admissions for central nervous system (CNS) disease. Whipple's disease has heterogeneous presentations for inpatient admissions, and disproportionately affects older males. High hospitalization rates in the Midwest support environmental and occupational disease transmission likely from the soil. Hospitalists should be aware of the various acute, subacute, and chronic presentations of this disease, and that acute presentations may be more common in the inpatient setting.

Indexed as

Whipple DiseaseCross-Sectional StudiesHumansInpatientsMaleMiddle AgedPrevalenceRisk FactorsTropherymaUnited States

Identifiers

PMID36626499
PMCPMC9750640
OpenAlexW4315436182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.